chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Vomiting
Clinical narrative: chills; vomiting; nausea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Left at 07:30 on 24Jan2021 (Batch/Lot Number: EL9261) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 intramuscular, administered in Arm Left at 07:40 on 04Jan2021 (Batch/Lot Number: EK9230) for COVID-19 immunization and experienced pain on left arm. The patient experienced chills on 29Jan2021, vomiting on 29Jan2021, nausea on 29Jan2021. No treatment received for events. The events were assessed as non-serious by reporter. The outcome of events was recovered in 2021.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Chest discomfort; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 26-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced chest discomfort on an unspecified date. The outcome of the event was unknown.  No follow up attempts needed. Information on lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: a rash all over her body; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration on 02Apr2021, as a single dose for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) for COVID-19 immunisation. The patient experienced rash all over her body on 20Apr2021. The patient wanted to know if this was a commonly reported side effect, if it goes away or if she would need to consult her HCP about this. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: This is a spontaneous report from a Non-contactable consumer (patient). A male patient of an unknown age reported that he had received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) via unknown route on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The patient historical vaccine included of BNT162B2 (at single dose for COVID-19 immunization. The patient had experienced diarrhoea and dizziness on an unspecified date. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: having a metallic tasts in her mouth; This is a spontaneous report received from a contactable consumer (patient). A 66-year-old female patient received a second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history stated she lost her sense of smell and had covid back in November. Patient historical vaccine included BNT162B2 (first dose) for COVID-19 immunization. Patient concomitant medications were not reported. Caller stated that she got her first vaccine dose and it went well. Then she went for her second dose and several days later she began having a metallic tasts in her mouth on an unspecified date. She didn't see this listed as a common side effect and reports that when she had Covid back in November "she had lost her sense of smell but she had no other symptoms". Patient reported that she still hasn't gotten her taste back yet and reports that her smell is coming back. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Has a lump under the arm that got injected.; This is a spontaneous report from a contactable consumer (patient's mother) via medical information team. A male patient (reporter's oldest son) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration, administered in Arm on 21Apr2021 at a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Apr2021, the patient experienced has a lump under the arm that got injected. The reporter stated that her whole family got vaccine on 21Apr2021. They all had a little bit of symptoms here and there but her oldest son has a lump under the arm that got injected. She is wondering if this is common, if it'll go away and if she should consult his doctor. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: This is a spontaneous report received from a contactable consumer. A 28-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on an unspecified date (Lot Number: EW0153) at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that he was not in pain or anything but he had about, he wanna said about half dollars size bump where the injection was and it's just red, it's kind of itchy. It's almost like he got the bite like mosquito or something but it's a big bump, so there was no pain he can still move arm it didn't hurt to touch or anything it's just itchy but he figured better safe then sorry and perhaps he should go ahead and at least get that reported to may be if that's just the normal thing. Event started within a week he got the vaccine. He wanted to know if he is going to loose an arm or if he is going to die from his reaction to the vaccine. The redness hasn't gone away, the bump was still there. The outcome of the events half dollars size bump where the injection was and it's just red was not recovered, of the other event was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: headache; This is a spontaneous report from a contactable consumer (patient). A 52-year-old patient of unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8732) intramuscularly, administered in Left Deltoid on 26Mar2021 at 14:30 at single dose for COVID-19 immunization in Hospital. Medical history included Eczema flare up on 03Mar2021 and ongoing, Menstruation fatigue from 03Mar2021, Soretonil from 03Mar2021. Family Medical History: Relevant to AEs included dad had stomach cancer died of complication after 1year, Mom had thyroid cancer remission over 40years. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6199, expiration date: 30Jun2021) intramuscularly, administered in Left Deltoid on 05Mar2021 at 14:30 (at the age of 52-year-old) at single dose for COVID-19 immunization and experienced fatigue exhaustion; swelling, with a pain full lump; pain and swelling along the left side of the neck/inflamed Lymph node. It was reported that after the second vaccine, experienced throeung HEADACHE for two days thus consumed eight acetometyston in the two days in Mar2021, stayed home than worked on the these day. No other symptoms. The patient underwent lab test which included COVID Test: Negative (Pre-colonoscopy test COVID required) on 28May2020. Therapeutic measures were taken as a result of the event. The outcome of the event was recovered in 2021 for duration of 2 days.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence, Panic attack
Clinical narrative: Had anxiety panic attack; Had anxiety panic attack; This is a spontaneous report from a Pfizer sponsored program COVAX US support. A contactable consumer(Patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 20Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included used to have panic attacks and has been many years. The patient's concomitant medications were not reported. The patient had 1st dose of covid vaccine yesterday on 20Apr2021. Said was fine yesterday but woke up this morning on 21Apr2021 and had anxiety panic attack. Patient was concerned. Used to have panic attacks and has been many years, patient was not taking any other medication so thinking it has to do with vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: This is a spontaneous report from a contactable consumer (patient) via medical information team. A 65-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via route of administration on 02Mar2021 at a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose BNT162B2 for Covid-19 Immunisation. A 65-year-old female stated that she had her second dose of the Pfizer Covid-19 vaccine on 02Mar2021 and three weeks later she started having chills that come sporadically, they disappear after a few minutes in Mar2021. The event was reported as non-serious. The outcome of the event was recovered in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: having severe cramping in her stomach; diarrhea; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 54-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 08Apr2021 (at the age of 54-years-old) at a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that she had the first dose of the vaccine on 08Apr2021 and 4 to 5 hours later started having severe cramping in her stomach and diarrhea and that lasted 4 days straight. She stated she is still having lingering diarrhea and it has been 2 weeks now. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Hypoaesthesia, Paraesthesia
Clinical narrative: This is a spontaneous report from a contactable consumer(the patient, reported for self). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration on an unspecified date (at the age of 65-year-old) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced back pain, arm fell asleep and patient noticed tingling needle like sensation around the tip of fingers (Medical Information Potential AE). Reporter, the patient wanted to know if this side effect has been reported with the vaccine. Seriousness of the event was reported as non-serious. The outcome of events was unknown.  No Follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: bad arm pain; severe chills; This is a spontaneous report from a contactable consumer (patient). A 73-year-old patient of an unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) intramuscularly, administered in left arm on 19Mar2021 at 13:50 (at age of 73 years old, Lot Number: ER 8727) as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previous took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) intramuscularly, administered in left arm on 26Feb2021 at 13:50 (Lot Number: EN6202) as single dose for covid-19 immunization and experienced severe headache. The patient experienced bad arm pain and severe chills on 19Mar2021 at 18:00. The outcome of events was recovered on 20Mar2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Gingival pain, Mastication disorder, Teething, Vaccination site pain
Clinical narrative: pain on her  teeth and gum; pain on her  teeth and gum; She can't chew, it hurts with warm or cold water; pain on the side where she had the vaccine; This is a spontaneous report received from a non-contactable consumer (mother). A female patient (daughter) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 17Apr2021 at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter stated that her daughter received the first dose do the Pfizer Covid-19 vaccine on Saturday 17Apr2021 and by Monday 19Apr2021, she started experiencing a terrible pain on her nerves, teeth and gum; like when you have a root canal. She can't chew, it hurts with warm or cold water. Stated that she has the pain on the side where she had the vaccine. She would like to know if there is available information regarding this side effect and if there is a recommended cure for this. The events were reported as non-serious. The outcome of the events was unknown.  No follow up attempts are possible; information about lot number/batch number cannot be obtained.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: low grade fever; This is a spontaneous report from a contactable consumer. A 72-year-old patient of unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6205 and expiration date were not reported) intramuscularly at Left arm on 04Mar2021 at single dose for covid-19 immunisation. Medical history was reported as none. The patient's concomitant includes levothyroxine for thyroid and atorvastatin for use cholesterol. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5318), via intramuscular route of administration on the left arm on 28Jan2021 at 3 PM as a single dose for COVID-19 immunization. Patient also received Shingrix Vial (Shingrix Vial; Lot Number: EN5318, Batch/Lot :73T27) on upper left arm on 15Jan2021. On 17Feb2021, SARS-Cov2 rapid Covid-19 was Negative, F SARS CoV 2 RNA was Negative and Cepheid SARS- CoV-2 RT, PCR assay was positive. To clarify- there were no adverse events to the first shot for patient. First shot was on 28Jan2021, symptoms of Covid-19 appeared Wednesday 17Feb2021. Wife had been diagnosed with Covid-19 on 08feb2021. Case of Covid-19 for the (withheld) was mild with fever and chills, fever on and off for a total of 9 days. No other symptoms, no loss of smell or taste. Patient had second shot on 04Mar2021, one week after symptoms stopped. Reaction to second shot was mild, a few hours of low-grade fever (date not specified). The outcome of the event low-grade fever was Recovered.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Fatigue; small periodic headaches; This is a spontaneous report received from a contactable consumer (patient). A 32-years-old female patient received BNT162B2, dose 2 via an unspecified route of administration on 19Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient received second Covid-19 vaccination on 19Apr2021. The patient stated she got fatigue and small periodic headaches on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: slight fever on and off; Chills; Slight headache; This is a spontaneous report from a contactable consumer or other non-healthcare professional via Pfizer sponsored program. Follow up (20Apr2021) received from a contactable consumer or other non-healthcare professional was processed together with initial information.   A 72-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included injured toe and patient was prescribed to take amoxicillin which he was waited 4 days after the vaccine to take the medication. The patient's concomitant medications were not reported. On an unspecified date, patient experienced a slight headache at the beginning of post authorization, has had a slight fever on and off lasting longer than 14 days post authorization and chills two weeks after receiving second dose of vaccine. Reporter mentioned that the patient took Tylenol for the fever and it will then go away. Reporter wanted to know that for how long patient can experience these side effects after receiving the vaccine. Reporter also wanted to know if there was any interaction with antivirals or amoxicillin. Outcome of the slight fever on and off was recovered while for the other events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Influenza like illness, Nasopharyngitis, Rash
Clinical narrative: Flu/cold-like symptoms; Flu/cold-like symptoms; Coughing up green stuff; Coughing up green stuff; Labored breathing; Rash; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date not reported), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) as a single dose for COVID-19 immunization. The patient experienced flu/cold-like symptoms, coughing up green stuff, labored breathing, and a rash on an unknown date. She went to the ED/ Emergency Room and they discharged her. She asked if these are symptoms other people experienced and the timeline of how long they may last. Seriousness of the events were reported as non-serious. The outcome of the events was unknown.   No follow-up attempts are needed. Information on lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum discoloured
Clinical narrative: Flu/cold-like symptoms; Flu/cold-like symptoms; Coughing up green stuff; Coughing up green stuff; Labored breathing; Rash; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date not reported), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) as a single dose for COVID-19 immunization. The patient experienced flu/cold-like symptoms, coughing up green stuff, labored breathing, and a rash on an unknown date. She went to the ED/ Emergency Room and they discharged her. She asked if these are symptoms other people experienced and the timeline of how long they may last. Seriousness of the events were reported as non-serious. The outcome of the events was unknown.   No follow-up attempts are needed. Information on lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Pain in extremity, Peripheral swelling
Clinical narrative: breast tenderness outside of her breast; soreness and swelling under her arms; swelling under her arms; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient received Pfizer COVID vaccine and stated she had breast tenderness outside of her breast that lasted a few days and soreness and swelling under her arms. She reported that the breast tenderness was closest to the armpit. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Lip dry, Vaccination site streaking
Clinical narrative: noticed a  red streak (between elbow and wrist); 5 tiny nonpainful blisters; Lips chapped and peeled; This is a spontaneous report from a contactable consumer (reporting for herself) via Medical information team. A 74-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date (at the age of 74-years) as SINGLE DOSE in Arm Left for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, days after she received the first shot of vaccination on the left arm, she noticed a red streak (between elbow and wrist) with 5 tiny nonpainful blisters. Also reported her Lips chapped and peeled after both shots of vaccination. She was advised to take Benadryl after the shot however she didn't take the Benadryl. Outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pyrexia
Clinical narrative: Chills; Flu like symptoms; Fever; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 13Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced chills, flu like symptoms and fever in Apr2021 after the first dose and would like to know how long symptoms were going to last. The events were reported as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling hot, Insomnia, Pain, Swelling
Clinical narrative: Pain; soreness in that left shoulder; swelling; Area was warm to touch; could not sleep last night; had light mild pain in left shoulder at the site of injection; This is a spontaneous report received from a contactable consumer (husband). This consumer reported for a 83-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 07Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. On an unknown date Medical history included cancer of thyroid, mitral valve replacement and use of a pacemaker. Concomitant medications were not reported. On Apr2021 the patient experienced had light mild pain in left shoulder at the site of and could not sleep last night; On 20Apr2021 the patient experienced pain and soreness in that left shoulder, swelling, area was warm to touch, could not sleep last night. The report received as, the reporter's wife got the first dose of the Pfizer Covid 19 vaccine on 07Apr2021 and had light mild pain in left shoulder at the site of injection for 2 days. Then 12 days later, on either 20Apr2021 or 21Apr2021, she developed pain and soreness in that left shoulder again, down to her elbow, with swelling and area was warm to touch. She did not have a fever. It bothers her and she could not sleep last night. She is scheduled for the second dose on 28Apr2021. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain; soreness in that left shoulder; swelling; Area was warm to touch; could not sleep last night; had light mild pain in left shoulder at the site of injection; This is a spontaneous report received from a contactable consumer (husband). This consumer reported for a 83-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 07Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. On an unknown date Medical history included cancer of thyroid, mitral valve replacement and use of a pacemaker. Concomitant medications were not reported. On Apr2021 the patient experienced had light mild pain in left shoulder at the site of and could not sleep last night; On 20Apr2021 the patient experienced pain and soreness in that left shoulder, swelling, area was warm to touch, could not sleep last night. The report received as, the reporter's wife got the first dose of the Pfizer Covid 19 vaccine on 07Apr2021 and had light mild pain in left shoulder at the site of injection for 2 days. Then 12 days later, on either 20Apr2021 or 21Apr2021, she developed pain and soreness in that left shoulder again, down to her elbow, with swelling and area was warm to touch. She did not have a fever. It bothers her and she could not sleep last night. She is scheduled for the second dose on 28Apr2021. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: She is experiencing a headache right now; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on 19Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was experiencing a headache right now after the first dose. She did take Tylenol and mentioned that she felt better. She was scheduled on 10May2021 for the second dose, she mentioned that she would not be available because she would be having a trip in a different state and her returning flight is in between of 10May to 16May2021. She wanted to know if she could reschedule it. The outcome of event headache was recovered.  No follow-up attempts are needed; information about batch/lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Acne, Eczema, Pain in extremity, Pruritus, Urticaria
Clinical narrative: my back, legs , arms were all  itchy; right inside ear canal itched a lot and my neck became itchy; sore arm; tiny bit of itching; small amount of hives on legs, hips, thighs, arms and scalp; I developed eczema around my neck; sore pimples on fore head; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 13Apr2021 17:30 as single dose for covid-19 immunisation. Medical history included polypropelene glycol (states an allergy to "polypropelene glycol). Concomitant medications included ascorbic acid, zinc (VITAMIN C + ZINC) at 1000mg every hour and 4 doses of Zinc15 mg over 15 hours, colecalciferol (VITAMIN D 3) at 5000 over 15 hour and nicotinic acid (NIACYN) all are taken for an unspecified indication, start and stop date were not reported. Patient received her 1st vaccine on 13Apr2021, at 5:30pm no she had no side effects. patient woke up at 0200 with a sore arm and took vitamin C 1000mg every hour after 2000 C no soreness at all. patient also took 4 doses of Zinc15 mg over 15 hours, vitamin D 5000 over 15 hours after having a tiny bit of itching. 24 hours later patient had spots on my feet and legs and itching, patient took vit C and it went away." patient states the next morning she woke up "itchy and used vit C and D and a niacyn flush." That night she "got itchy, small amount of hives on legs, hips, thighs, arms and scalp", she took vit C and anti-itch cream and the vit C and "meds helped", also took vit D, zinc. "started getting sore pimples on forehead Thursday for a week, really sore pimples. Friday, 16Apr right inside ear canal itched a lot and my neck became itchy. Saturday 17Apr my back, legs, arms were all itchy. patient took vit C and it went away. patient developed eczema around my neck (like a collar) and ears were still itchy but no body shaking. 18Apr itchy neck and back, one cherry sized hive on my shoulder. slightly raised and itchy. 19Apr had to take vit C after bath/shower every day." Patient states she felt better than "got 5 areas on my scalp, were like a bite, small like a spider bite. 20Apr one full week at night still itchy. 21Apr went back to normal. 04May Caller has her 2nd vaccine dose scheduled. The outcome of the events hives, Eczema, pimples and Itching - generalised was unknown and other events was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: slight fever; cough; This is spontaneous report received from a contactable clinician. A 71-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 16Apr2021 as single dose for covid-19 immunisation; and palbociclib (IBRANCE) 125mg, via oral route from 12Feb2021 (Batch/Lot number was not reported) and ongoing, at dose 15 mg, cyclic 21 days on, 7 off for breast cancer. Patient receivedbnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on unknown date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced slight fever and cough on Apr2021. with outcome of recovered. No other problems. primary md aware of vaccine issue and asked pt to notify oncologist. seeing md 26Mar2021. The action taken for palbociclib was unknown. The outcome of the event was resolved.  No Follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: mild fever; targeted muscle aches in the arm on the non injection site; This is a spontaneous report from a contactable consumer (patient) via Medical information Team and via a Pfizer-sponsored program. A 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 06Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild fever and targeted muscle aches in the arm on the non injection site on an unspecified date in Apr2021. The patient took some Tylenol for it. The patient wanted to know about the timing of the second dose as he is going to get tested for the COVID. Patient was scheduled on 27Apr2021 for second dose of vaccine. The patient will undergo COVID-19 test and asked if it will turn out negative, is it okay to get the second dose of the vaccine. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: arm soreness and a headache; arm soreness/arm hurt a little bit; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 22Apr2021 at 14:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had experienced arm soreness and a headache on Apr2021. The patient wants to know if he got any side effects, can he use ibuprofen for headaches or arm hurts at the injection site. It was also reported that the patient's friend said to take the ibuprofen and the patient's daughter said to take ibuprofen or paracetamol (TYLENOL). The patient was referred to health care professional (HCP) for treatment recommendations. The outcome of these events was unknown at the reporting time.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pain in extremity
Clinical narrative: pain between legs; pain between legs, hip; back pain lower left side.; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization. Medical history included old injuries. Concomitant medications were not reported. The patient experienced pain between legs, hip and back pain lower left side. Patient was still experiencing it after 1 week. It was asked if it was known that old injuries could make symptoms worse. The patient had not recovered from the events.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Neck pain
Clinical narrative: headache; neck pain; swollen lymph nodes under her neck, ears; This is a spontaneous report from a non-contactable consumer (patient) via medical information team. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration dates were not reported), via an unspecified route of administration, on an 09Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in Apr2021, patient experienced headache and neck pain. Two weeks later, after vaccine (in Apr2021), patient also experienced swollen lymph nodes under her neck, ears. Patient was scheduled to receive the 2nd dose on 30Apr2021. Patient wanted to know what would happen if she does not receive the 2nd dose and if this is a normal reaction to the vaccine, how long it would last, and if she should still receive the 2nd dose. Patient also wanted to know what medications are given for these reactions. Seriousness of the events was reported as non-serious. The outcome of the events was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: the local spasm at the injection site; This is a spontaneous report from a Pfizer sponsored program COVAX US support. A contactable consumer (patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 18Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced the local spasm at the injection site on 20Apr2021 with outcome of unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Son had fever from the last dose; This is a spontaneous report received from a non-contactable consumer (patient's mother) via Pfizer Sponsored Program. A male patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after first vaccine, the patient had fever. Reporter stated that second dose was schedule for 19 days instead of 21 days and wanted to know if she was able to schedule it for the 21 days according to the information she found. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: he noticed his hair has started falling out; This is a spontaneous report from a contactable consumer (patient). A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration, on 15Apr2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously took historical vaccine, first dose of BNT162B2 for Covid-19 immunization. Since receiving the vaccine, that was on 15 Apr2021, he noticed his hair has started falling out. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on arms and legs with no itching or pain; This is a spontaneous report from a contactable consumer (Patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient experienced side effects of hives on arms and legs with no itching or pain. Patient asked that is this a common side effect and what is an anaphylactic allergic reaction. The outcome of the event was Unknown.  No follow up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Gait inability, Headache, Joint injury
Clinical narrative: He also gets headaches in the morning around the same time; He has become a real dreamer and only sleeps three hours a night/ he has never been a dreamer and now has about 9 dreams a night; 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk/It attacked his right knee and ankle; 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 60-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 02Mar2021 at single dose for COVID-19 immunization. Medical history included stent being placed. Concomitant medications included acetylsalicylic acid (ASPIRIN 81) at 81 mg, daily. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. Patient stated he has received both doses of the Pfizer COVID vaccine and he received the second dose on 02Mar2021. Patient states he has been healthy all his life minus a stent being placed. Patient stated 12 hours after receiving the second dose of the vaccine it attacked his left knee and he couldn't walk in Mar2021. Patient stated the next morning his left knee was fine but then it attacked his right knee and ankle in Mar2021. He also gets headaches in the morning around the same time on 03Mar2021. Patient stated he has become a real dreamer and only sleeps three hours a night. Patient states he has never been a dreamer and now has about 9 dreams a night in Mar2021. Patient states he was not able to take a lot of ibuprofen and he only takes an 81 mg aspirin daily. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes; This is a spontaneous report received from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (Batch/Lot number was not reported), Solution for injection, via unspecified route of administration on 19Apr2021 (dose number: 02) at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 20Apr2021, patient experienced swollen lymph nodes and had taken Tylenol and started putting warm compress since yesterday, but swelling was still the same. Patient wanted to know how long these symptoms can last and also if any medical treatment can be recommended. Representative stated that Swollen lymph nodes (lymphadenopathy), which generally get resolved within 10 days, was likely to have resulted from a robust vaccine-elicited immune response. Patient should always talk with a vaccination provider, doctor, or other qualified health care professional about whether a specific treatment or medication was right for you and before starting a new treatment or activity. The outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Somnolence, Vaccination site warmth
Clinical narrative: Site of injection feels hot; Numbness on her arm; Her left hand and arm had tingling; Feel a sleep; This is a spontaneous report received from a contactable consumer (patient herself). A female patient of an age 38 (unspecified unit) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 04Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she received her first dose of the Pfizer covid vaccine today and 30 minutes later her left hand and arm had tingling and feel asleep is this normal. Patient just received the first dose of the COVID-19 vaccine today (04Apr2021) and her 2nd dose schedule would be on 14May2021. She said that she is experiencing numbness on her arm and she added that the site of injection feels hot. The outcome of the events was unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I started to feel dizzy, when I was sitting in the car first 15 minutes; This is a spontaneous report received from contactable consumer (patient). A 60-year-old female Patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported) via unspecified route of administration on 08Apr2021 as single dose for Covid-19 immunisation. Medical history and concomitant medication were not reported. Patient started to feel dizzy, when patient was sitting in the car first 15 minutes on an unspecified date in 2021, my husband said, maybe you are worked up. I did not think much of it. I have been having Dizziness off and on since then. patient not sure patient wants to take the second dose is there a recommendation? The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Reports "low grade" fever 100.8, 100; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced, received second dose Monday.  On an unspecified date, patient experienced "low grade" fever 100.8, 100. Caller asks if she were concerned as most people she know symptoms only endured a couple of days. Patient received response that frequency and percentages of participants with solicited local reactions, by maximum severity, within 7 days after each dose, participants 18-55 years of age, reactogenicity subset of the safety population refer to HCP. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.